|
|
 |
|
ARDM: Aradigm Corp - Stock News |
Enter Ticker:
|
|
| Nov 18, 2009 |
Aradigm Begins Dosing in Phase 2 Study for the Management of Respiratory Infections in Bronchiectasis |
| Nov 16, 2009 |
Aradigm Doses First Patient in Long-Term Phase 2 Study of a Novel Inhaled Ciprofloxacin Formulation for the Management of Respiratory Infections in Bronchiectasis |
| Nov 05, 2009 |
StockProfiler.US: Stock Watch: ARDM, CERP, NOBV |
| Nov 05, 2009 |
GreenArrowStock.com: Green Zone Watch at GreenArrowStock.com: Aradigm Corporation (ARDM). |
| Nov 05, 2009 |
Aradigm Announces Third Quarter 2009 Financial Results |
| Oct 22, 2009 |
Aradigm to Present at the 8th Annual BIO Investor Forum on October 28 |
| Sep 18, 2009 |
Aradigm Presents Results from Its Phase 2a Clinical Trial in Non-Cystic Fibrosis Bronchiectasis Patients |
| Sep 14, 2009 |
Fastmoneytalk.com: Vivakor, Inc. & Aradigm Corporation Profiled by FastMoneyTalk.com |
| Sep 14, 2009 |
Equedia: Video Streams and Trading Data for Aradigm Corporation |
| Sep 14, 2009 |
Aradigm Presents Data Demonstrating Significant Antibacterial Concentrations and Effects in Non-Cystic Fibrosis Bronchiectasis Patients Following Administration of its Once-Daily Inhaled Liposomal Ciprofloxacin |
| Sep 09, 2009 |
Emerging Stock Report Initiates Independent Research Coverage On Aradigm Corp. |
| Aug 10, 2009 |
Aradigm Gets Orphan Drug Designation for Inhaled Liposomal Ciprofloxacin to Treat Cystic Fibrosis in Europe |
| Aug 07, 2009 |
www.babybulls.com: Alerts For Friday, August 7, 2009: BMOD, AIMM, ARDM, INSV And NEOP |
| Aug 07, 2009 |
BiomedReports: News and FDA Updates for XenoPort (Nasdaq:XNPT), Aradigm (OTCBB:ARDM), Targacept (NASDAQ:TRGT), ACADIA (Nasdaq: ACAD) |
| Aug 06, 2009 |
BiomedReports: News and FDA Updates for XenoPort (Nasdaq:XNPT), Aradigm (OTCBB:ARDM), Targacept (NASDAQ:TRGT), ACADIA (Nasdaq: ACAD) |
| |
| ZACKS COMMENTARY FOR ARDM |
|
|
|
Sponsored Links 
-0.01